ACUJJA
DEAD

Serial Number

90058864

Owner

Sierra Oncology, Inc.

Attorney

Christopher M. Hanes

Filing Date

Jul 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ACUJJA Trademark

Serial Number: 90058864

ACUJJA is a trademark filed by Sierra Oncology, Inc. on July 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Sierra Oncology, Inc. (8 trademarks)

Corporation Service Company
Wilmington, DE 19808

Entity Type: 03

Trademark Details

Filing Date

July 17, 2020

Registration Date

Not Registered

Published for Opposition

June 8, 2021

Goods & Services

Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; Medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use

Medical services; medical testing services; DNA screening and analysis services for medical purposes

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; scientific research and development; scientific laboratory services; medical laboratory services; conducting clinical trials for others; conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes

Filing History

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 19, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 19, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 19, 2022 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 12, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 12, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 12, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 12, 2022 REAP
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 7, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 7, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 3, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 8, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 8, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 19, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2021 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 27, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 27, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 27, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 27, 2021 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 30, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 30, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 30, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2020 NWOS
NEW APPLICATION ENTERED
Jul 21, 2020 NWAP